Form 8-K - Current report:
SEC Accession No. 0001193125-25-119386
Filing Date
2025-05-14
Accepted
2025-05-14 07:14:24
Documents
16
Period of Report
2025-05-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d940594d8k.htm   iXBRL 8-K 35972
2 EX-99.1 d940594dex991.htm EX-99.1 23283
6 GRAPHIC g940594g61l42.jpg GRAPHIC 1909
7 GRAPHIC g940594g79o18.jpg GRAPHIC 1631
  Complete submission text file 0001193125-25-119386.txt   196474

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sepn-20250513.xsd EX-101.SCH 2857
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sepn-20250513_lab.xml EX-101.LAB 17979
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sepn-20250513_pre.xml EX-101.PRE 11263
18 EXTRACTED XBRL INSTANCE DOCUMENT d940594d8k_htm.xml XML 3633
Mailing Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080
Business Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080 650-338-3533
Septerna, Inc. (Filer) CIK: 0001984086 (see all company filings)

EIN.: 843891440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42382 | Film No.: 25942626
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)